98%
921
2 minutes
20
Breast cancer (BCa) poses a severe threat to women's health worldwide as it is the most frequently diagnosed type of cancer and the primary cause of death for female patients. The biopsy procedure remains the gold standard for accurate and effective diagnosis of BCa. However, its adverse effects, such as invasiveness, bleeding, infection, and reporting time, keep this procedure as a last resort for diagnosis. A mammogram is considered the routine noninvasive imaging-based procedure for diagnosing BCa, mitigating the need for biopsies; however, it might be prone to subjectivity depending on the radiologist's experience. Therefore, we propose a novel, mammogram image-based BCa explainable AI (BCaXAI) model with a deep learning-based framework for precise, noninvasive, objective, and timely manner diagnosis of BCa. The proposed BCaXAI leverages the Inception-ResNet V2 architecture, where the integration of explainable AI components, such as Grad-CAM, provides radiologists with valuable visual insights into the model's decision-making process, fostering trust and confidence in the AI-based system. Based on using the DDSM and CBIS-DDSM mammogram datasets, BCaXAI achieved exceptional performance, surpassing traditional models such as ResNet50 and VGG16. The model demonstrated superior accuracy (98.53%), recall (98.53%), precision (98.40%), F1-score (98.43%), and AUROC (0.9933), highlighting its effectiveness in distinguishing between benign and malignant cases. These promising results could alleviate the diagnostic subjectivity that might arise as a result of the experience-variability between different radiologists, as well as minimize the need for repetitive biopsy procedures.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11544836 | PMC |
http://dx.doi.org/10.3390/cancers16213668 | DOI Listing |
JMIR Hum Factors
September 2025
KK Women's and Children's Hospital, Singapore, Singapore.
Background: Breast cancer treatment, particularly during the perioperative period, is often accompanied by significant psychological distress, including anxiety and uncertainty. Mobile health (mHealth) interventions have emerged as promising tools to provide timely psychosocial support through convenient, flexible, and personalized platforms. While research has explored the use of mHealth in breast cancer prevention, care management, and survivorship, few studies have examined patients' experiences with mobile interventions during the perioperative phase of breast cancer treatment.
View Article and Find Full Text PDFJAMA Surg
September 2025
Department of Population Health, NYU Grossman School of Medicine, New York, New York.
Int J Surg
September 2025
Department of Neurosurgery, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, People's Republic of China.
Med Oncol
September 2025
Department of Biotechnology, Institute of Engineering and Management, University of Engineering and Management, Kolkata, Kolkata, India.
Oligomeric proanthocyanidins (OPCs), condensed tannins found plentiful in grape seeds and berries, have higher bioavailability and therapeutic benefits due to their low degree of polymerization. Recent evidence places OPCs as effective modulators of cancer stem cell (CSC) plasticity and tumor growth. Mechanistically, OPCs orchestrate multi-pathway inhibition by destabilizing Wnt/β-catenin, Notch, PI3K/Akt/mTOR, JAK/STAT3, and Hedgehog pathways, triggering β-catenin degradation, silencing stemness regulators (OCT4, NANOG, SOX2), and stimulating tumor-suppressive microRNAs (miR-200, miR-34a).
View Article and Find Full Text PDF